Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-17-023490
Filing Date
2017-05-01
Accepted
2017-05-01 09:23:04
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1/A v465628_s1a.htm S-1/A 500091
2 EXHIBIT 1.1 v465628_ex1-1.htm EX-1.1 185337
3 EXHIBIT 4.18 v465628_ex4-18.htm EX-4.18 101191
4 EXHIBIT 4.19 v465628_ex4-19.htm EX-4.19 104550
5 EXHIBIT 5.1 v465628_ex5-1.htm EX-5.1 16143
6 EXHIBIT 23.1 v465628_exh23-1.htm EX-23.1 2376
7 GRAPHIC line.gif GRAPHIC 43
8 GRAPHIC spacer.gif GRAPHIC 43
9 GRAPHIC logo_ampliphi.jpg GRAPHIC 42798
10 GRAPHIC pg1img1_ex5-1.jpg GRAPHIC 9484
  Complete submission text file 0001144204-17-023490.txt   983361
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-217169 | Film No.: 17798815
SIC: 2836 Biological Products, (No Diagnostic Substances)